The authors proposed a molecular subregional effect, according to which variants closer to the NPRL2/NPRL3 binding site (where DEPDC5 binds to exert its inhibitory effect on the mTOR pathway) may lead to more severe phenotypes featuring cortical dysplasia (34). Here, NPRL3 is linked to cerebral cortical dysplasia.